Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial

التفاصيل البيبلوغرافية
العنوان:	Neoadjuvant durvalumab with or without stereotactic body radiotherapy in patients with early-stage non-small-cell lung cancer: a single-centre, randomised phase 2 trial
المؤلفون:	Altorki, Nasser K ^*, McGraw, Timothy E, Borczuk, Alain C, Saxena, Ashish, Port, Jeffrey L, Stiles, Brendon M, Lee, Benjamin E, Sanfilippo, Nicholas J, Scheff, Ronald J, Pua, Bradley B, Gruden, James F, Christos, Paul J, Spinelli, Cathy, Gakuria, Joyce, Uppal, Manik, Binder, Bhavneet, Elemento, Olivier, Ballman, Karla V, Formenti, Silvia C
المصدر:	In The Lancet Oncology June 2021 22(6):824-835
قاعدة البيانات:	ScienceDirect

كن أول من يترك تعليقا!